DNMT3A GENE MUTATION

Clinical trials for DNMT3A GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new DNMT3A GENE MUTATION trials appear

Sign up with your email to follow new studies for DNMT3A GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Common diabetes drug tested to stop leukemia from coming back

Disease control Not yet recruiting

This study is testing if metformin, a common diabetes medication, can reduce the level of a specific genetic mutation found in some patients with acute leukemia who are currently in remission. The goal is to see if lowering this mutation can help prevent the cancer from returning…

Matched conditions: DNMT3A GENE MUTATION

Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC

DNMT3A GENE MUTATION

Get alerted when new DNMT3A GENE MUTATION trials appear

Common diabetes drug tested to stop leukemia from coming back